Curi Wealth Management, LLC Edwards Lifesciences Corp Transaction History

Curi Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$61.71 - $77.76 $185 - $233	-3 Reduced 0.08%	3,980 $303,000
Q3 2023 Nov 06, 2023	SELL	$69.28 - $93.38 $3,948 - $5,322	-57 Reduced 1.41%	3,983 $275,000
Q1 2023 May 03, 2023	SELL	$74.26 - $84.51 $74 - $84	-1 Reduced 0.02%	4,040 $334,000
Q4 2022 Feb 03, 2023	BUY	$68.3 - $87.44 $136 - $174	2 Added 0.05%	4,041 $301,000
Q2 2022 Aug 08, 2022	BUY	$86.5 - $128.27 $6,660 - $9,876	77 Added 1.94%	4,039 $384,000
Q3 2021 Oct 19, 2021	SELL	$102.91 - $122.75 $61,951 - $73,895	-602 Reduced 13.19%	3,962 $448,000
Q4 2020 Mar 19, 2021	BUY	$71.69 - $91.23 $327,193 - $416,373	4,564 New	4,564 $416,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Curi Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Curi Wealth Management, LLC with notifications on news.